Literature DB >> 14684330

Novel targeting strategy based on multimeric ligands for drug delivery and molecular imaging: homooligomers of alpha-MSH.

Josef Vagner1, Heather L Handl, Robert J Gillies, Victor J Hruby.   

Abstract

Homooligomers constructed with 4- and 6-amino acid fragments of melanocortin (alpha-MSH) bind with higher affinity and with apparent cooperativity to melanocortin receptor, compared to their constituent monomers. Individual ligands were tethered with various spacers of different length and rigidity and the influence of spacers on binding was studied. Binding assays were performed on cells transfected with the melanocortin receptor, hMC4R. There is a 5-7-fold decrease in the EC(50) with the addition of each subunit, going from monomer to trimer. The Hill coefficient increases from 0.76 for the monomer to 1.12 for the dimer and 1.35 for the trimer. These data show a general trend of increasing avidity with increasing number of ligands in oligomers.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14684330     DOI: 10.1016/j.bmcl.2003.09.079

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  32 in total

1.  Cell-specific targeting by heterobivalent ligands.

Authors:  Jatinder S Josan; Heather L Handl; Rajesh Sankaranarayanan; Liping Xu; Ronald M Lynch; Josef Vagner; Eugene A Mash; Victor J Hruby; Robert J Gillies
Journal:  Bioconjug Chem       Date:  2011-06-16       Impact factor: 4.774

2.  A sucrose-derived scaffold for multimerization of bioactive peptides.

Authors:  Venkataramanarao Rao; Ramesh Alleti; Liping Xu; Narges K Tafreshi; David L Morse; Robert J Gillies; Eugene A Mash
Journal:  Bioorg Med Chem       Date:  2011-08-27       Impact factor: 3.641

3.  Design, synthesis, and validation of a branched flexible linker for bioactive peptides.

Authors:  Martina E Bowen; Yasunari Monguchi; Rajesh Sankaranarayanan; Josef Vagner; Lucinda J Begay; Liping Xu; Bhumasamudram Jagadish; Victor J Hruby; Robert J Gillies; Eugene A Mash
Journal:  J Org Chem       Date:  2007-02-06       Impact factor: 4.354

4.  Near-infrared fluorescence imaging of tumor integrin alpha v beta 3 expression with Cy7-labeled RGD multimers.

Authors:  Yun Wu; Weibo Cai; Xiaoyuan Chen
Journal:  Mol Imaging Biol       Date:  2006 Jul-Aug       Impact factor: 3.488

5.  Heterobivalent ligands crosslink multiple cell-surface receptors: the human melanocortin-4 and delta-opioid receptors.

Authors:  Josef Vagner; Liping Xu; Heather L Handl; Jatinder S Josan; David L Morse; Eugene A Mash; Robert J Gillies; Victor J Hruby
Journal:  Angew Chem Int Ed Engl       Date:  2008       Impact factor: 15.336

6.  Multivalent activation of GLP-1 and sulfonylurea receptors modulates β-cell second-messenger signaling and insulin secretion.

Authors:  Nathaniel J Hart; Craig Weber; Klearchos K Papas; Sean W Limesand; Josef Vagner; Ronald M Lynch
Journal:  Am J Physiol Cell Physiol       Date:  2018-11-07       Impact factor: 4.249

7.  Development of melanoma-targeted polymer micelles by conjugation of a melanocortin 1 receptor (MC1R) specific ligand.

Authors:  Natalie M Barkey; Narges K Tafreshi; Jatinder S Josan; Channa R De Silva; Kevin N Sill; Victor J Hruby; Robert J Gillies; David L Morse; Josef Vagner
Journal:  J Med Chem       Date:  2011-11-10       Impact factor: 7.446

8.  Synthesis and evaluation of bivalent ligands for binding to the human melanocortin-4 receptor.

Authors:  Steve M Fernandes; Yeon Sun Lee; Robert J Gillies; Victor J Hruby
Journal:  Bioorg Med Chem       Date:  2014-10-02       Impact factor: 3.641

9.  An in Vitro and in Vivo Investigation of Bivalent Ligands That Display Preferential Binding and Functional Activity for Different Melanocortin Receptor Homodimers.

Authors:  Cody J Lensing; Katie T Freeman; Sathya M Schnell; Danielle N Adank; Robert C Speth; Carrie Haskell-Luevano
Journal:  J Med Chem       Date:  2016-03-29       Impact factor: 7.446

10.  Discovery of high-affinity protein binding ligands--backwards.

Authors:  Chris W Diehnelt; Miti Shah; Nidhi Gupta; Paul E Belcher; Matthew P Greving; Phillip Stafford; Stephen Albert Johnston
Journal:  PLoS One       Date:  2010-05-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.